COVID-19
Operation Warp Speed succeeded on the development component but is failing in the early stages of distribution. Here’s everything you need to know about it.
The U.S. Department of Defense awarded Moderna a contract worth $1,966,598,000 for an additional 100 million doses of its COVID-19 vaccine.
The United Kingdom is expected to give the green light to the vaccine developed by AstraZeneca and Oxford University this week.
The vaccine will be able to be administered without needles and in one dose. It also won’t require refrigeration.
BioSpace spoke with just a couple of companies endeavoring to make 2021 a happier new year for survivors now suffering from the life-altering after-effects of COVID-19.
Yesterday it was reported that the two companies were working to make more of their vaccine than the 1.3 billion it promised to manufacture in 2021.
It has been thought that llamas may hold the key to developing an effective therapeutic against COVID-19, as well as the flu. This morning, scientists from the National Institutes of Health made additional headway in llama research, isolating promising antibodies from the South American animal.
Please check out the biopharma industry coronavirus (COVID-19) stories that are trending for December 29, 2020.
Every week there are numerous scientific studies published. Here’s a look at some of the more interesting ones.
At the moment, eight clinical trials are currently being carried out to determine if the link between melatonin and the novel coronavirus is legitimate.
PRESS RELEASES